Giovanni Bader

2.0k total citations
52 papers, 1.6k citations indexed

About

Giovanni Bader is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giovanni Bader has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giovanni Bader's work include Diabetes Treatment and Management (15 papers), Diabetes Management and Research (13 papers) and Lipoproteins and Cardiovascular Health (8 papers). Giovanni Bader is often cited by papers focused on Diabetes Treatment and Management (15 papers), Diabetes Management and Research (13 papers) and Lipoproteins and Cardiovascular Health (8 papers). Giovanni Bader collaborates with scholars based in Switzerland, Italy and United States. Giovanni Bader's co-authors include Leopoldo Sarli, L Roncoroni, Carlo Salvemini, Davide Di Mauro, Antonio Mazzeo, Domenico Iusco, Gerhard M. Kostner, Robert Fogel, Pierre‐Jean Touboul and Patrizio Prati and has published in prestigious journals such as Diabetes Care, Stroke and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Giovanni Bader

49 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giovanni Bader Switzerland	21	485	459	398	369	361	52	1.6k
Yoshiaki Kawaguchi Japan	22	341 0.7×	623 1.4×	458 1.2×	571 1.5×	548 1.5×	102	2.2k
Hiromitsu Iwamoto Japan	20	266 0.5×	364 0.8×	286 0.7×	333 0.9×	394 1.1×	54	1.5k
Jens Passauer Germany	22	281 0.6×	373 0.8×	135 0.3×	163 0.4×	446 1.2×	44	1.5k
Maya Ish‐Shalom Israel	16	180 0.4×	311 0.7×	369 0.9×	375 1.0×	197 0.5×	35	1.2k
Tracy McGowan United States	19	389 0.8×	217 0.5×	144 0.4×	398 1.1×	270 0.7×	43	2.2k
Yasuhiro Izumiya Japan	20	261 0.5×	311 0.7×	127 0.3×	159 0.4×	722 2.0×	82	1.4k
Keisuke Ohba Japan	15	384 0.8×	344 0.7×	186 0.5×	135 0.4×	946 2.6×	24	1.7k
Julian Donckier Belgium	23	753 1.6×	588 1.3×	94 0.2×	225 0.6×	650 1.8×	112	1.8k
for the RED-CABG Steering Committee and Investigators United States	8	268 0.6×	531 1.2×	147 0.4×	93 0.3×	445 1.2×	10	1.6k
I. Paterson United States	13	133 0.3×	364 0.8×	157 0.4×	239 0.6×	156 0.4×	22	1.3k

Countries citing papers authored by Giovanni Bader

Since Specialization

Citations

This map shows the geographic impact of Giovanni Bader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Bader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Bader more than expected).

Fields of papers citing papers by Giovanni Bader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Bader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Bader. The network helps show where Giovanni Bader may publish in the future.

Co-authorship network of co-authors of Giovanni Bader

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Bader. A scholar is included among the top collaborators of Giovanni Bader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Bader. Giovanni Bader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D’Urzo, Anthony, Giovanni Bader, Steven S. Shen, Pankaj Goyal, & Pablo Altman. (2018). Comparison of glycopyrronium versus tiotropium on the time to clinically important deteriorations in patients with COPD: a post-hoc analysis of randomized trials. npj Primary Care Respiratory Medicine. 28(1). 18–18. 6 indexed citations

Rodrigo, Gustavo J., David Price, Antonio Anzueto, et al.. (2017). LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis. International Journal of COPD. Volume 12. 907–922. 113 indexed citations

Wang, Chenyu, Heidi Beadnall, Sean N. Hatton, et al.. (2016). Automated brain volumetrics in multiple sclerosis: a step closer to clinical application. Journal of Neurology Neurosurgery & Psychiatry. 87(7). 754–757. 46 indexed citations

Vogelmeier, Claus, Nanshan Zhong, Michael Humphries, et al.. (2016). Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis. International Journal of COPD. Volume 11. 3189–3197. 12 indexed citations

Blüher, Matthias, Anja Schweizer, Giovanni Bader, & James E. Foley. (2014). Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes. Vascular Health and Risk Management. 10. 661–661. 13 indexed citations

Göke, Rüdiger, Giovanni Bader, & Markus Dworak. (2014). Real-Life Effectiveness and Tolerability of Vildagliptin and Other Oral Glucose-Lowering Therapies in Patients with Type 2 Diabetes in Germany. Diabetes Therapy. 5(1). 183–191. 5 indexed citations

Åhrén, Bo, Chantal Mathieu, Giovanni Bader, Anja Schweizer, & James E. Foley. (2014). Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies. Diabetologia. 57(7). 1304–1307. 37 indexed citations

Bader, Giovanni, et al.. (2013). Vildagliptin more effectively achieves a composite endpoint of HbA1c<7.0% without hypoglycaemia and weight gain compared with glimepiride after 2 years of treatment. Diabetes Research and Clinical Practice. 100(3). e78–e81. 18 indexed citations

Gilet, Hélène, Jean-Bernard Gruenberger, Giovanni Bader, & Muriel Viala-Danten. (2012). Demonstrating the Burden of Hypoglycemia on Patients' Quality of Life in Diabetes Clinical Trials: Measurement Considerations for Hypoglycemia. Value in Health. 15(8). 1036–1041. 12 indexed citations

10.

Pan, Changyu, Xiaoping Xing, Ping Han, et al.. (2012). Efficacy and tolerability of vildagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 14(8). 737–744. 70 indexed citations

11.

Nishiwaki, Masato, Katsunori Ikewaki, Giovanni Bader, et al.. (2006). Human Lecithin:Cholesterol Acyltransferase Deficiency. Arteriosclerosis Thrombosis and Vascular Biology. 26(6). 1370–1375. 20 indexed citations

12.

Azzoni, Cinzia, Lorena Bottarelli, Nicoletta Campanini, et al.. (2006). Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. International Journal of Colorectal Disease. 22(2). 115–126. 91 indexed citations

13.

Prati, Patrizio, Diego Vanuzzo, Marco Casaroli, et al.. (2006). Determinants of Carotid Plaque Occurrence. Cerebrovascular Diseases. 22(5-6). 416–422. 40 indexed citations

14.

Rigatelli, Gianluca, et al.. (2005). Evidence against the widespread use of angiography of noncoronary arteries during coronary artery angiography and cardiac catheterization. Cardiovascular revascularization medicine. 6(2). 48–51. 7 indexed citations

15.

Sarli, Leopoldo, Lorena Bottarelli, Cinzia Azzoni, et al.. (2004). Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer. European Journal of Cancer. 40(10). 1581–1588. 22 indexed citations

16.

Sarli, Leopoldo, Lorena Bottarelli, Giovanni Bader, et al.. (2004). Association Between Recurrence of Sporadic Colorectal Cancer, High Level of Microsatellite Instability, and Loss of Heterozygosity at Chromosome 18q. Diseases of the Colon & Rectum. 47(9). 1467–1482. 35 indexed citations

17.

Bader, Giovanni, Giovanni Zuliani, Gerhard M. Kostner, & R. Fellin. (1998). Apolipoprotein E Polymorphism Is Not Associated with Longevity or Disability in a Sample of Italian Octo- and Nonagenarians. Gerontology. 44(5). 293–299. 39 indexed citations

18.

Zuliani, Giovanni, Stefano Volpato, Giovanni Bader, et al.. (1997). High-density lipoprotein cholesterol strongly discriminates between healthy free-living and disabled octo-nonagenarians: A cross sectional study. Aging Clinical and Experimental Research. 9(5). 335–341. 14 indexed citations

19.

Kraft, H.G., Arno Lingenhel, Giovanni Bader, Gerhard M. Kostner, & Gerd Utermann. (1996). The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes. Atherosclerosis. 125(1). 53–61. 45 indexed citations

20.

Zuliani, Giovanni, Giovanni Bader, Tiziana Imbastaro, et al.. (1995). Lipoprotein(a) plasma levels and apo(a) isoforms are not associated with longevity or disability in a sample of Italian octo- nonagenarians. Aging Clinical and Experimental Research. 7(5). 385–391. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact